- Home
- PRTA vs TKNO Comparison
PRTA vs TKNO Comparison
Compare PRTA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- TKNO
- Stock Information
- Founded
- PRTA 2012
- TKNO 1996
- Country
- PRTA Ireland
- TKNO United States
- Employees
- PRTA N/A
- TKNO N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- PRTA Health Care
- TKNO Health Care
- Exchange
- PRTA Nasdaq
- TKNO Nasdaq
- Market Cap
- PRTA 472.1M
- TKNO 256.9M
- IPO Year
- PRTA N/A
- TKNO 2021
- Fundamental
- Price
- PRTA $8.20
- TKNO $4.35
- Analyst Decision
- PRTA Buy
- TKNO
- Analyst Count
- PRTA 10
- TKNO 0
- Target Price
- PRTA $14.86
- TKNO N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- TKNO 224.0K
- Earning Date
- PRTA 08-04-2025
- TKNO 08-07-2025
- Dividend Yield
- PRTA N/A
- TKNO N/A
- EPS Growth
- PRTA N/A
- TKNO N/A
- EPS
- PRTA N/A
- TKNO N/A
- Revenue
- PRTA $10,341,000.00
- TKNO $38,923,000.00
- Revenue This Year
- PRTA N/A
- TKNO $9.52
- Revenue Next Year
- PRTA $389.77
- TKNO $15.20
- P/E Ratio
- PRTA N/A
- TKNO N/A
- Revenue Growth
- PRTA N/A
- TKNO 11.40
- 52 Week Low
- PRTA $4.32
- TKNO $4.00
- 52 Week High
- PRTA $22.83
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- TKNO 43.35
- Support Level
- PRTA $8.05
- TKNO $4.22
- Resistance Level
- PRTA $8.73
- TKNO $4.94
- Average True Range (ATR)
- PRTA 0.38
- TKNO 0.29
- MACD
- PRTA -0.05
- TKNO -0.00
- Stochastic Oscillator
- PRTA 47.62
- TKNO 16.75
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.